Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Runqiu Jiang

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Journal of Clinical Pathology|October 28, 2011
Hepatic haemangiomas: possible association with IL-17ZhaoJing Wang, Yifeng Yuan, Haiwen Zhuang, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 6, 2020
RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcriptionJianjun Wang, Feng Huang, Yaxiang Shi, et al.
Life Sciences|October 23, 2020
The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventerEman D Mohammed, Ashraf B Abdel-Naim, Jin Kangpeng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2014
Survival and inflammation promotion effect of PTPRO in fulminant hepatitis is associated with NF-κB activationRunqiu Jiang, Dianyu Chen, Jiajie Hou, et al.
Molecular Carcinogenesis|February 3, 2015
The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinomaHan Zhuo, Junwei Tang, Zhe Lin, et al.
Chemico-Biological Interactions|May 31, 2024
Diallyl trisulfide induces pyroptosis and impairs lung CSC-like properties by activating the ROS/Caspase 1 signaling pathwayChunfeng Xie, Xu Zhou, Weiyi Chen, et al.
Oncology Letters|January 26, 2026
Phosphorylated-EGFR and MMP7 upregulation in gastric cancer: Association with metastasis and poor prognosisBiran Ding, Yiqiu Wan, Yao Wu, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinomaWenjie Zhang, Yang Liu, Zhongyi Yan, et al.
Hepatology (Baltimore, Md.)|June 16, 2011
Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3Runqiu Jiang, Zhongming Tan, Lei Deng, et al.
International Journal of Cancer|September 4, 2009
High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancerRunqiu Jiang, Yongxiang Xia, Jun Li, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Journal of Clinical Pathology|October 28, 2011
Hepatic haemangiomas: possible association with IL-17ZhaoJing Wang, Yifeng Yuan, Haiwen Zhuang, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 6, 2020
RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcriptionJianjun Wang, Feng Huang, Yaxiang Shi, et al.
Life Sciences|October 23, 2020
The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventerEman D Mohammed, Ashraf B Abdel-Naim, Jin Kangpeng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2014
Survival and inflammation promotion effect of PTPRO in fulminant hepatitis is associated with NF-κB activationRunqiu Jiang, Dianyu Chen, Jiajie Hou, et al.
Molecular Carcinogenesis|February 3, 2015
The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinomaHan Zhuo, Junwei Tang, Zhe Lin, et al.
Chemico-Biological Interactions|May 31, 2024
Diallyl trisulfide induces pyroptosis and impairs lung CSC-like properties by activating the ROS/Caspase 1 signaling pathwayChunfeng Xie, Xu Zhou, Weiyi Chen, et al.
Oncology Letters|January 26, 2026
Phosphorylated-EGFR and MMP7 upregulation in gastric cancer: Association with metastasis and poor prognosisBiran Ding, Yiqiu Wan, Yao Wu, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinomaWenjie Zhang, Yang Liu, Zhongyi Yan, et al.
Hepatology (Baltimore, Md.)|June 16, 2011
Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3Runqiu Jiang, Zhongming Tan, Lei Deng, et al.
International Journal of Cancer|September 4, 2009
High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancerRunqiu Jiang, Yongxiang Xia, Jun Li, et al.
Pageof 8